出生前親子鑑定

What are the advantages and disadvantages of conducting a paternity test during pregnancy?

親子

↓今すぐDNA出生前親子鑑定を予約する↓

簡単WEB予約はこちら

Summary of this article

Paternity testing during pregnancy provides valuable information in various situations. For example, confirming the father before birth allows for the early establishment of the parent-child relationship. However, this test also has disadvantages, such as mental stress, ethical issues, and financial costs. Taking these pros and cons into account, let’s take a closer look at the options and impacts of conducting a paternity test during pregnancy.

Several advantages to conducting a paternity test during pregnancy

Early Confirmation

If there are doubts about the parent-child relationship, conducting the test during pregnancy allows for the confirmation of who the father is before the child is born. This makes it possible to establish the parent-child relationship before birth.

Mental Peace of Mind

Once paternity is confirmed, the relationship between the potential father and the mother may improve, providing mental stability. Additionally, resolving uncertainty can reduce stress and anxiety within the family.

Legal Preparation

If the parent-child relationship is confirmed, legal procedures can be prepared before the child is born. This includes processes like recognition of paternity and addressing future issues such as custody and child support.

Medical Reasons

If there is a risk of certain genetic disorders being passed from the father to the child, paternity testing can identify this risk in advance, allowing for the preparation of necessary medical measures.

To fully benefit from these advantages, it is important to consult with doctors and experts and conduct the paternity test in an appropriate manner. Ethical considerations are also required, and the consent of all involved parties is necessary.

What are the disadvantages?

Mental Stress

If the results of the paternity test differ from expectations, it can cause significant stress or conflict within the family. Especially if the results do not align with family expectations, the impact can be immeasurable.

Ethical Issues

Conducting a paternity test during pregnancy can be subject to ethical debates. In particular, social consensus is needed on how to consider the rights of the future child and the authority of parents in making decisions related to the child.

Cost

Paternity tests can incur high costs. Especially if the test is conducted safely during pregnancy, the technical requirements may increase the cost further.

Considering these disadvantages, it is recommended to decide whether or not to conduct a paternity test after thoroughly evaluating its necessity, risks, and ethical considerations.

Hiro Clinic’s DNA Prenatal Paternity Testing

Hiro Clinic’s DNA Prenatal Paternity Testing (NIPPT) is available at the industry’s lowest price at Hiro Clinic’s directly managed locations nationwide. Testing can be done from the 6th week of pregnancy onward, and the process is completed in a single visit, minimizing inconvenience. If a retest is necessary, it will be conducted free of charge, so you can rest assured. Additionally, tests are conducted at the Tokyo Sanitary Laboratory, which has over 50,000 cases of prenatal testing experience, ensuring reliable results. However, both partners are required to visit the clinic to ensure the most accurate test results. For more information, please check here and make your reservation or inquiry.

医師監修 監修日：2024年9月1日

岡 博史 （おか ひろし）

医師・医学博士 ／ ヒロクリニック統括院長

YouTubeチャンネルなどを通じて、遺伝子やNIPT（新型出生前診断）についてわかりやすく発信しています。

略歴

  • 1996年 慶應義塾大学医学部 卒業
  • 2004年 慶應義塾大学 医学博士号 取得
  • 2005年 慶應義塾大学 皮膚科学教室 助手
  • 2008年 ヒロ皮フ形成クリニック 開業
  • 2009年 医療法人社団福美会 理事長
  • 2015年 医療法人社団福美会 理事

資格・所属

  • CAPラボディレクター
  • 日本皮膚科学会 皮膚科専門医
  • 日本医師会 産業医
  • 東京衛生検査所 指導監督医

発信・関連リンク

この記事は、 ヒロクリニックNIPPTの編集・監修体制 にもとづき、資格を持つ医師が内容を確認しています。

医師監修 監修日：2024年9月1日

堤 修一 （つつみ しゅういち）

医師・医学博士 ／ ヒロクリニック博多駅前院 院長

略歴

  • 1993年 東京大学医学部医学科 卒業
  • 2016〜2019年 東京大学先端科学技術研究センター 准教授

発信・関連リンク

この記事は、 ヒロクリニックNIPPTの編集・監修体制 にもとづき、資格を持つ医師が内容を確認しています。

参考文献

  1. Gregg AR, Skotko BG, Benkendorf JL, Monaghan KG, Bajaj K, Best RG, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2016 Oct;18(10):1056-1065.
  2. Rose NC, Kaimal AJ, Dugoff L, Norton ME; American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics; Committee on Genetics; Society for Maternal-Fetal Medicine. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstet Gynecol. 2020 Oct;136(4):e48-e119.
  3. Japan Society of Obstetrics and Gynecology. Guidelines for non-invasive prenatal testing (NIPT) using maternal blood. Tokyo: Japan Society of Obstetrics and Gynecology; 2013.
  4. Japanese Society of Human Genetics, Japan Society of Gene Counseling, editors. Textbook for Clinical Genetics Specialists, Vol. 1: Foundations of Clinical Genetics. Tokyo: Shindan to Chiryosha; 2019.
  5. Japanese Society of Human Genetics, Japan Society of Gene Counseling, editors. Textbook for Clinical Genetics Specialists, Vol. 2: Practice of Clinical Genetic Medicine. Tokyo: Shindan to Chiryosha; 2019.

Latest Articles

Supervisor of the article

Dr. Hiroshi Oka

Director of CAP Laboratory

Graduated from Keio University, Faculty of Medicine

Doctor of Medicine

Medical Doctor